Aquilo Capital, L.P., 10% Owner at Spero Therapeutics, Inc. (SPRO), bought 47,416 shares at $7.63 ($362K) on 2022-03-14, disclosed to the SEC on 2022-03-16.
Open-market purchase of $362k SPRO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.63 | 8,006 | $61K | 16.9% |
| 2 | $7.63 | 8,006 | $61K | 16.9% |
| 3 | $7.63 | 15,702 | $120K | 33.1% |
| 4 | $7.63 | 15,702 | $120K | 33.1% |
| Total | $7.63 avg | 47,416 | $362K | 100% |
| Filing → |
| SPRO | BUY | 2022-01-26 | $17K | — | Filing → |
| SPRO | BUY | 2021-11-02 | $2.6M | — | Filing → |
| SPRO | BUY | 2021-10-04 | $5.0M | — | Filing → |